I. Hall

发表

Substituted cyclic imides as potential anti-gout agents.

D. Reynolds, I. Hall, J. Scoville, 1990, Life sciences.

The Cytotoxic Principles of Prunella vulgaris, Psychotria serpens, and Hyptis capitata: Ursolic Acid and Related Derivatives1

K. Lee, I. Hall, T. Yamagishi, 1988, Planta medica.

Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

T. G. Waddell, K. Lee, K. Lee, 1977, Science.

Synthesis and Cytotoxicity of Cyanoborane Adducts of N 6 -Benzoyladenine and 6-Triphenylphosphonylpurine

I. Hall, Joshua D. Berkowitz, B. Burnham, 2002, Metal-based drugs.

In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450.

S. Chaney, K. Lee, I. Hall, 1991, Biochemical pharmacology.

In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone.

S. Chaney, K. Lee, I. Hall, 1989, Biochemical pharmacology.

Acute toxicity of helenalin in BDF1 mice.

S. Chaney, D. Reynolds, K. Lee, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Effectiveness of THAM in Preventing Cellular Damage Resulting From Oxygen Lack.∗

I. Hall, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Antitumor agents based on natural product models. Edited by John M. Cassady and John D. Douros. Academic, 111 Fifth Ave., New York, NY 10003. 1980. 500 pp. 15 × 23 cm

I. Hall, 1982 .

Hypolipidemic, anti-inflammatory, and antineoplastic activity and cytotoxicity of flavonolignans isolated from Hydnocarpus wightiana seeds.

D. Sharma, I. Hall, 1991, Journal of natural products.

The Effects of Phthalimide and Saccharin Derivatives on Low-Density Lipoprotein (LDL) and High-Density Lipoprotein (HDL) Receptor Activity and Related Enzyme Activities

S. Wyrick, I. Hall, O. T. Wong, 1988, Pharmaceutical Research.

Hypolipidemic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, and sulfones.

J. Sowell, I. Hall, J. Chapman, 1989, Journal of pharmaceutical sciences.

Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.

I. Hall, G. Cocolas, A. R. Murthy, 1985, Journal of pharmaceutical sciences.

Antihyperlipidemic activity of phthalimide analogues in rodents.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of pharmaceutical sciences.

In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes

I. Hall, U. Schwab, T. Ives, 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Effects of alatrofloxacin, the parental prodrug of trovafloxacin, on phagocytic, anti-inflammatory and immunomodulation events of human THP-1 monocytes.

I. Hall, U. Schwab, T. Ives, 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection.

I. Hall, U. Schwab, T. Ives, 2003, Life sciences.

Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.

S. Chaney, K. Lee, A. Grippo, 1988, Anticancer research.

Relationship of Hypolipidemic and Antineoplastic Activities of Tricyclohexyl‐ and Triphenylphosphine Boranes, Carboxyboranes, Cyanoboranes, and Related Derivatives

K. Morse, I. Hall, P. Maiti, 1992, Archiv der Pharmazie.

Anti-inflammatory agents III: Structure-activity relationships of brusatol and related quassinoids.

K. Lee, I. Hall, Y. Imakura, 1983, Journal of pharmaceutical sciences.

Antitumor agents XLVI: In vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells.

K. Lee, I. Hall, M. Okano, 1982, Journal of pharmaceutical sciences.

The Anti‐inflammatory Activiy of Metal Complexes of Heterocyclic Thiosemicarbazones, 2‐Substituted Pyridine N‐Oxides and 2‐Pyridylthioureas

I. Hall, D. West, K. Rajendran, 1996 .

The anti‐inflammatory activity of metal complexes and salts of amine carboxyboranes

K. Morse, I. Hall, K. Rajendran, 1994 .

Tricarbonylrhenium(I) complexes of phosphine-derivatized amines, amino acids and a model peptide: structures, solution behavior and cytotoxicity

J. Vittal, Y. Yan, I. Hall, 2002 .

Relationship between amine-carboxyboranes and TNF alpha for the regulation of cell growth in different tumor cell lines.

C. Woods, I. Hall, M. C. Miller, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Mechanism of action of the antitumor agents 6‐benzoyl‐3,3‐disubstituted‐1,5‐diazabicyclo[3.1.0]hexane‐2,4‐diones: Potent inhibitors of human type II inosine 5′‐monophosphate dehydrogenase

A. Eakin, B. Barnes, I. Hall, 2001, International journal of cancer.

Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.

A. Eakin, B. Barnes, I. Hall, 2001, The Journal of pharmacology and experimental therapeutics.

Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death.

A. Eakin, B. Barnes, I. Hall, 2001, Biochemical pharmacology.

Tmolt4 Leukemic Type II Isoform of IMP Dehydrogenase as a Target for 1,2,4‐Triazolidine‐3,5‐diones, 1‐(1‐(3‐Methylphenyl)ethylidineamino)‐4,4‐diethyl‐3,5‐azetidinediones, 3,5‐Isoxazolidinediones, and 4,4‐Disubstituted‐3,5‐pyrazolidinediones

B. Barnes, I. Hall, E. S. Ward, 2001, Archiv der Pharmazie.

The Hypolipidemic Activity of 3-Iminophthalimidine in Rodents

I. Hall, G. Cocolas, P. J. Voorstad, 1984, Pharmaceutical Research.

Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.

K. Lee, I. Hall, T. Ibuka, 1981, Journal of pharmaceutical sciences.

Anti-inflammatory activity of amine cyanoboranes, amine carboxyboranes, and related compounds.

A. McPhail, I. Hall, C. Starnes, 1980, Journal of pharmaceutical sciences.

Mode of action of sesquiterpene lactones as anti-inflammatory agents.

T. G. Waddell, K. Lee, I. Hall, 1980, Journal of pharmaceutical sciences.

Effects of 2-(2,4-dimethylphenyl)indan-1,3-dione on serum lipoprotein and lipid metabolism of rodents

I. Hall, A. R. Murthy, P. Day, 1988, Lipids.

Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives

J. Maguire, I. Hall, A. R. Murthy, 1986, Lipids.

The Effects of N(4-Methylphenyl)diphenimide on Lipid Metabolism of Sprague Dawley Rats

D. Reynolds, I. Hall, O. T. Wong, 1992, Pharmaceutical Research.

Hypolipidemic Activity of 3‐Amino‐1‐(2,3,4‐mononitro‐, mono‐, or dihalophenyl)propan‐1‐ones in Rodents

I. Hall, Yunsheng Huang, 1996, Archiv der Pharmazie.

Hypolipidemic effects of α, β, and γ-alkylaminophenone analogs in rodents

I. Hall, Y. Huang, Yung-Feng Huang, 1996 .

Synthesis and Pharmacological Studies of 3‐Amino‐2‐methyl‐1‐phenylpropanones as Hypolipidemic Agents in Rodents

Yun-Jing Huang, I. Hall, Y. Huang, 1996, Archiv der Pharmazie.

Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-diones in rodents.

I. Hall, O. T. Wong, R. Izydore, 1993, Journal of pharmaceutical sciences.

Hypolipidemic Effects of 2‐Furoic Acid in Sprague‐Dawley Rats

D. Reynolds, I. Hall, J. Chang, 1993, Archiv der Pharmazie.

Hypolipidaemic activity in rodents of boron analogs of phosphonoacetates and cyanoborane adducts of dialkyl aminomethylphosphonates.

C. K. Sood, K. Morse, I. Hall, 1992, Pharmacological research.

The hypolipidemic activity of alkylamines and their borane derivatives: structure-activity relationship in rodents

I. Hall, E. Docks, T. S. Griffin, 1991 .

Synthesis and Hypolipidemic Activity of Amine‐Carboxyboranes, and Their Amides and Esters in Rodents

C. K. Sood, K. Morse, I. Hall, 1991, Archiv der Pharmazie.

The hypolipidemic activity of heterocyclic amine boranes in rodents.

I. Hall, A. Sood, B. Spielvogel, 1991, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Hypolipidemic Activity in Rodents of Phenobarbital and Related Derivatives

M. A. Patrick, J. Maguire, I. Hall, 1990, Archiv der Pharmazie.

The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents.

I. Hall, O. T. Wong, A. R. Murthy, 1987, Pharmacological research communications.

Hypolipidemic activity of trimethylamine-carbomethoxyborane and related derivatives in rodents.

I. Hall, A. Sood, B. Spielvogel, 1987, Journal of pharmaceutical sciences.

Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.

I. Hall, E. Docks, T. S. Griffin, 1986, Journal of pharmaceutical sciences.

Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.

S. Wyrick, I. Hall, A. R. Murthy, 1986, Journal of pharmaceutical sciences.

Targeting of Human Tmolt4 Leukemic Type II IMP Dehydrogenase by Cyclic Imide Related Derivatives

B. Barnes, I. Hall, S. E. Cho, 2001, Archiv der Pharmazie.

Specific inhibition of Type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3‐methoxy and di‐benzohydroxamic acids, maleic hydrazide and malonic acids

B. Barnes, I. Hall, E. S. Ward, 2001, The Journal of pharmacy and pharmacology.

The cytotoxicity of 1-(phenylmethyl)-4,7,10-tris-[(4'methylphenyl) sulfonyl]-1,4,7,10-tetraazacyclododecane in human Tmolt3 T leukemic cells.

I. Hall, S. Karthikeyan, B. Spielvogel, 1997, Anticancer research.

Succinate: Protective Agent against Hyperbaric Oxygen Toxicity

A. P. Sanders, I. Hall, B. Woodhall, 1965, Science.

Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents

I. Hall, O. T. Wong, R. Izydore, 1993, Lipids.

The Hypolipidemic Activity of Benzenetricarboxylic Acids in Rodents

I. Hall, J. M. Chapman, C. Gilbert, 1984, Pharmaceutical Research.

Investigation of 3,5-Isoxazolidinediones as Hypolipidemic Agents in Rodents

M. Debnath, I. Hall, O. T. Wong, 2004, Pharmaceutical Research.

Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.

I. Hall, O. T. Wong, R. Izydore, 1994, Journal of pharmaceutical sciences.

Hypolipidemic activity of boronated nucleosides and nucleotides in rodents.

I. Hall, B. Shaw, K. Rajendran, 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Hypolipidemic effects of 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid in rats and tissue culture cells.

D. Reynolds, I. Hall, R. Simlot, 1993, Journal of pharmaceutical sciences.

Terephthalic Acid in Sprague‐Dawley Rats as a Hypolipidemic Agent

D. Reynolds, I. Hall, R. Simlot, 1993, Archiv der Pharmazie.

Antitumor agents XXIX: Effects of eupahyssopin on nucleic acid, protein, anaerobic, and aerobic metabolism of Ehrlich ascites tumor cells.

K. Lee, I. Hall, S. A. Eigebaly, 1978, Journal of pharmaceutical sciences.

Antitumor agents XXVII: Effects of helenalin on anaerobic and aerobic metabolism of Ehrlich ascites cells.

K. Lee, I. Hall, S. A. Eigebaly, 1978, Journal of pharmaceutical sciences.

Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalin.

S. Chaney, K. Lee, I. Hall, 1983, Biochimica et biophysica acta.

Hypolipidemic Activity of o-(N-Phthalimido)acetophenone in Sprague Dawley Rats

D. Reynolds, I. Hall, C. B. Oswald, 1987, Pharmaceutical Research.

Antineoplastic agents III: effects of dibromoethyl and vinyl esters of N-benzyloxycarbonyl-l-phenylalanine on Ehrlich ascites tumor cell metabolism.

I. Hall, Z. Sajadi, L. Loeffler, 1978, Journal of pharmaceutical sciences.

Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.

S. Wyrick, J. Maguire, I. Hall, 1984, Journal of pharmaceutical sciences.

Antitumor agents. XXXIV: Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells.

K. Lee, I. Hall, Y. Imakura, 1979, Journal of pharmaceutical sciences.

Hypolipidemic activity of antiepileptic 5-phenylhydantoins in mice.

J. Maguire, I. Hall, A. R. Murthy, 1985, European journal of pharmacology.

The anti-osteoporotic activity of amine-carboxyboranes in rodents.

I. Hall, K. Rajendran, A. Sood, 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Antifertility activity of N-protected glycine activated esters.

I. Hall, L. Loeffler, J. Drew, 1981, Journal of pharmaceutical sciences.

Antifertility and antiproteolytic activity of activated N-carbobenzoxy amino acid esters.

I. Hall, Z. Sajadi, L. Loeffler, 1979, Journal of pharmaceutical sciences.

The Anti‐inflammatory Activity of N‐Substituted Indazolones in Mice

Yun-Jing Huang, L. Butner, I. Hall, 1996, Archiv der Pharmazie.

Anti-inflammatory and analgesic activities of 3-imino-1-oxoisoindolines in CF1 mice.

L. Butner, I. Hall, Y. Huang, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Structure Activity Relationships of 4‐Substituted 1‐Acyl and 1,2‐Diacyl‐1,2,4‐triazolidine‐3,5‐diones as Anti‐inflammatory Agents in Rodents

I. Hall, R. Izydore, R. Simlot, 1995, Archiv der Pharmazie.

Anti-inflammatory and anti-osteoporotic activities of base-boronated nucleosides and phosphate-boronated nucleotides in rodents.

I. Hall, B. Shaw, K. Rajendran, 1994, Journal of pharmaceutical sciences.

Structure and stereochemistry of (−)-odorinol, an antileukemic diamide from Aglaia odorata☆

N. Hayashi, A. McPhail, K. Lee, 1982 .

Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.

T. G. Waddell, K. Lee, I. Hall, 1977, Journal of medicinal chemistry.

Synthesis and Hypolipidemic Activity of 3-Imino-l-oxoisoindolines in Rodents

D. Reynolds, I. Hall, O. T. Wong, 1987, Pharmaceutical Research.

The Hypolipidemic Activity of Heterocyclic Thiosemicarbazones, Thioureas and Their Metal Complexes in Sprague Dawley Male Rats

B. Barnes, I. Hall, S. Y. Chen, 1999, Metal-based drugs.

Cycloalkanones. I. Stereochemistry of .alpha.,.alpha.'-dibenzylcycloalkanones

C. Piantadosi, I. Hall, G. Carlson, 1972 .

The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones.

I. Hall, M. C. Miller, J. R. Vance, 1998, Anticancer research.

Stability constants of potent cytotoxic copper(II) complexes with furan semicarbazones in ethanolic solutions.

G. Ibrahim, I. Hall, G. Bouet, 2000, Journal of inorganic biochemistry.

Cycloalkanones. 2. Synthesis and biological activity of alpha, alpha'-dibenzylcycloalkanones.

C. Piantadosi, I. Hall, G. Carlson, 1973, Journal of medicinal chemistry.

Antineoplastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells.

I. Hall, R. Simlot, M. C. Miller, 1992, Anticancer research.

The anti‐neoplastic activity of 2,3‐dihydrophthalazine‐1,4‐dione and N‐butyl‐2,3‐dihydrophthalazine‐1,4‐dione in human and murine tumor cells

I. Hall, E. Hall, O. T. Wong, 1992, Anti-cancer drugs.

Hypolipidemic activity of phthalimide derivatives. 7. Structure-activity studies of indazolone analogues.

S. Wyrick, I. Hall, G. Cocolas, 1984, Journal of medicinal chemistry.

Hypolipidemic activity of phthalimide derivatives IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of pharmaceutical sciences.

Hypolipidemic activity of substituted 2-pyrrolidinones in rodents.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of pharmaceutical sciences.

Hypolipidemic activity of phthalimide derivatives. 1. N-Substituted phthalimide derivatives.

I. Hall, J. Chapman, G. Cocolas, 1979, Journal of medicinal chemistry.

Multiple mechanisms for cytotoxicity induced by copper(II) complexes of 2‐acetylpyrazine‐N‐substituted thiosemicarbazones

I. Hall, M. C. Miller, J. R. Vance, 1999 .

The Cytotoxicity of Symmetrical and Unsymmetrical Bis(thiosemicarbazones) and Their Metal Complexes in Murine and Human Tumor Cells

I. Hall, H. Beraldo, L. Ackerman, 2000, Archiv der Pharmazie.

The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells.

I. Hall, A. E. Liberta, K. Rajendran, 1993, Anti-cancer drugs.

The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides.

I. Hall, A. E. Liberta, K. Rajendran, 1993, Anti-cancer drugs.

The Cytotoxicity of 2‐Formyl and 2‐Acetyl‐(6‐picolyl)‐4N‐Substituted Thiosemicarbazones and Their Copper(II) Complexes

I. Hall, Merrill C. Miller III, K. Bastow, 1998, Archiv der Pharmazie.

Cytotoxicity of copper complexes of 2-furaldehyde oxime derivatives in murine and human tissue cultured cell lines.

F. Bouet, I. Hall, M. C. Miller, 1997, Anticancer research.

Cytotoxicity of Substituted Alkyl‐3,4‐bis(4‐methoxyphenyl)pyrrole‐2‐carboxylates in L1210 Lymphoid Leukemia Cells

J. Gupton, I. Hall, B. Bowers, 1998, Archiv der Pharmazie.

Investigations on the Mechanism of Action of the Novel Antitumor Agents 2‐Benzothiazolyl, 2‐Benzoxazolyl, and 2‐Benzimidazolyl Hydrazones Derived from 2‐Acetylpyridine

I. Hall, G. Heinisch, G. Pürstinger, 1999, Archiv der Pharmazie.

Synthesis and Cytotoxicity of Substituted Ethyl 2‐Phenacyl‐3‐phenylpyrrole‐4‐carboxylates

J. Gupton, I. Hall, Joshua D. Berkowitz, 2003, Archiv der Pharmazie.

From boron analogues of amino acids to boronated DNA: potential new pharmaceuticals and neutron capture agents

I. Hall, B. Shaw, A. Sood, 1991 .

Hypolipidemic activity of phthalimide derivatives. 3. A comparison of phthalimide and 1,2-benzisothiazolin-3-one 1,1-dioxide derivatives to phthalimidine and 1,2-benzisothiazoline 1,1-dioxide congeners.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of medicinal chemistry.

Synthesis and Cytotoxic Action of 3,5‐Isoxazolidinediones and 2‐Isoxazolin‐5‐ones in Murine and Human Tumors

M. Debnath, I. Hall, R. Izydore, 1997, Archiv der Pharmazie.

Antineoplastic Activity of a Series of Boron Analogues of α-Amino Acids

A. McPhail, K. Morse, I. Hall, 1985 .

Antihyperlipidemic activity of amine cyanoboranes, amine carboxyboranes, and related compounds.

A. McPhail, I. Hall, P. Wisian-Neilson, 1981, Journal of pharmaceutical sciences.

Boron analogs of the .alpha.-amino acids. Synthesis, x-ray crystal structure, and biological activity of ammonia-carboxyborane, the boron analog of glycine

A. McPhail, I. Hall, K. Onan, 1980 .

Cytotoxicity of boron containing dipeptide analogs

I. Hall, S. Karthikeyan, J. Tomasz, 1995, Amino Acids.

Boron substituted deoxyribonucleosides as cytotoxic agents.

I. Hall, J. Tomasz, A. Sood, 1996, Anticancer research.

The Pharmacological Activities of the Metabolites of N-[(Trimethylamineboryl)-Carbonyl]-L-Phenylalanine Methyl Ester

I. Hall, R. Shrewsbury, M. C. Miller, 1996, Metal-based drugs.

Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolism.

I. Hall, C. Starnes, P. Wisian-Neilson, 1979, Journal of pharmaceutical sciences.

Antitumor agents. 31. Helenalin sym-dimethylethylenediamine reaction products and related derivatives.

K. Lee, I. Hall, T. Ibuka, 1978, Journal of medicinal chemistry.

Synthesis and antitumor evaluation of selected 5,6-disubstituted 1(2)H-indazole-4,7-diones.

I. Hall, L. Loeffler, G. A. Conway, 1983, Journal of medicinal chemistry.

Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.

K. Lee, I. Hall, Y. S. Wu, 1977, Journal of medicinal chemistry.

Antitumor agents. 16. Steroidal alpha-methylene-gamma-lactones.

E. Huang, K. Lee, I. Hall, 1975, Journal of medicinal chemistry.

Antitumor agents. 86. Synthesis and cytotoxicity of alpha-methylene-gamma-lactone-bearing purines.

K. Lee, V. Amarnath, I. Hall, 1987, Journal of medicinal chemistry.

Antitumor agents 32. Synthesis and antitumor activity of cyclopentenone derivatives related to helenalin.

K. Lee, I. Hall, E. Mar, 1978, Journal of medicinal chemistry.

Cytotoxicity of tantalum(V) and niobium(V) small carborane complexes and mode of action in P388 lymphocytic leukemia cells

M. Finn, J. Russell, B. Barnes, 2000 .

Synthesis, cytotoxicity, hypolipidemic and anti-inflammatory activities of amine-boranes and esters of boron analogues of choline and thiocholine.

C. K. Sood, I. Hall, A. Sood, 1992, Journal of pharmaceutical sciences.

Synthesis, X-ray structures, and cytotoxicity of rhenium(I) carbonyl 2-(dimethylamino)ethoxide complexes

J. Vittal, Y. Yan, I. Hall, 2002 .

Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells.

L. Sneddon, I. Hall, S. Mueller, 2003, Journal of inorganic biochemistry.

Cationic Metallatricarbadecaboranyl Analogues of Metallocene Antitumor Agents: Synthesis, Structure, and Antineoplastic Activity of [1‐(η5‐C5H5)Fe‐2‐Me‐2,3,4‐C3B7H9]+[X]− Salts (X− = AsF 6−, SbF 6−)

L. Sneddon, Christian C. Lee, P. Carroll, 1997 .

The synthesis and antitumor activity of metal complexes of amine-carboxyborane adducts

I. Hall, M. C. Miller, A. Sood, 1998 .

The cytotoxicity of trifluoromethyl boron derivatives and mode of action in human Tmolt3 T leukemic cells

B. Barnes, I. Hall, G. Pawelke, 2000 .

Cytotoxicity of Metallic Complexes of Furan Oximes in Murine and Human Tissue Cultured Cell Lines

Christian C. Lee, G. Ibrahim, I. Hall, 1999 .

Synthesis and antineoplastic activity of some cyano-, carboxy-, carbomethoxy-, and carbamoylborane adducts of heterocyclic amines.

C. K. Sood, I. Hall, A. Sood, 1991, Journal of pharmaceutical sciences.

DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines.

K. Morse, I. Hall, A. Sood, 1991, Anti-cancer drugs.

The antineoplastic activity of trimethylamine carboxyboranes and related esters and amides in murine and human tumor cell lines.

I. Hall, A. Sood, B. Spielvogel, 1990, Anti-cancer drugs.

Antimalarial agents. III. Mechanism of action of artesunate against Plasmodium berghei infection.

K. Lee, I. Hall, C. B. Oswald, 1987, Chemical & pharmaceutical bulletin.

Cycloalkanones. 4. Antifertility activity.

C. Piantadosi, I. Hall, G. Carlson, 1974, Journal of medicinal chemistry.

The Cytotoxicity of Trifluoromethyl Boron Derivatives and Mode of Action in Human Tmolt3 T Leukemic Cells.

B. Barnes, I. Hall, G. Pawelke, 2000 .

Cytotoxicity of ferratricarbadecaboranyl complexes in murine and human tissue cultured cell lines.

C. C. Lee, L. Sneddon, I. Hall, 1998, Anticancer Research.

The Synthesis and Antitumor Activity of the Sodium Salt and Copper (II) Complex of N-[(Trimethylamineboryl)-Carbonyl]-L-Phenylalanine Methyl Ester

I. Hall, M. C. Miller, A. Sood, 1998, Metal-Based Drugs.

Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts

I. Hall, Merrill C. Miller, K. Bastow, 1997, Metal-based drugs.

The anti‐neoplastic activity of ethylamine‐carboxyborane and triphenylphosphine‐carboxyborane in L‐1210 lymphoid leukemia cells

I. Hall, E. Hall, K. Bastow, 1992 .

Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds.

I. Hall, P. Micca, R. Fairchild, 1989, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Hypolipidemic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis(trimethylamin e- carboxyborane)-dicopper(II) in rodents and its effect on lipid metabolism.

A. McPhail, I. Hall, W. Williams, 1984, Journal of pharmaceutical sciences.

Antineoplastic and Cytotoxic Activities of Nickel(II) Complexes of Thiosemicarbazones

I. Hall, Merrill C. Miller, D. X. West, 1997, Metal-Based Drugs.

Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinoma.

A. McPhail, I. Hall, B. Spielvogel, 1984, Journal of pharmaceutical sciences.

Substituted 4-hydroxyproline di- and tri-peptides as cytotoxic agents

I. Hall, S. Y. Chen, 2005, Amino Acids.

The effects of boron containing peptides on L1210 lymphoid leukemia metabolism

I. Hall, E. Hall, M. C. Miller, 1993, Amino Acids.

Cytoxicity of [(5,6-dichloro-9a-n-propyl-2,3,9,9a-tetrahydro-3-oxo-1H fluoren-7-yl)oxy]acetic acid, an agent known to reduce brain edema.

S. Wyrick, I. Hall, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Cytotoxicity and Antineoplastic Activities of Alkylamines and Their Borane Derivatives

I. Hall, E. Tse, Rosallah A. Muhammad, 1996, Metal-based drugs.

The effects of genkwadaphnin and gnidilatidin on the growth of P-388, L-1210 leukemia and KB carcinoma cells in vitro.

K. Lee, I. Hall, C. B. Oswald, 1986, European Journal of Cancer and Clinical Oncology.

Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.

S. Chaney, K. Lee, A. Grippo, 1988, Journal of pharmaceutical sciences.

The cytotoxicity of N-Pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimide.

I. Hall, J. Scovill, O. T. Wong, 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Inhibition of DNA synthesis in P388 lymphocytic leukemia cells of BDF1 mice by cis-diamminedichloroplatinum(II) and its derivatives.

S. Chaney, I. Hall, C. B. Oswald, 1990, Journal of pharmaceutical sciences.

Antitumor agents LXIII: the effects of microlenin on nucleic acid and protein syntheses of Ehrlich ascites cells.

K. Lee, I. Hall, Y. Imakura, 1983, Journal of pharmaceutical sciences.

Effects of 3-chloromethylthiochromone-1,1-dioxide on nucleic acid, protein, and aerobic and anaerobic metabolism of Ehrlich ascites tumor cells.

I. Hall, L. Loeffler, M. H. Holshouser, 1982, Journal of pharmaceutical sciences.

Antitumor agents LIII: The effects of daphnoretin on nucleic acid and protein synthesis of Ehrlich ascites tumor cells.

K. Lee, K. Tagahara, I. Hall, 1982, Journal of pharmaceutical sciences.

Antitumor agents LII: The effects of molephantinin on nucleic acid and protein synthesis of Ehrlich ascites cells.

K. Lee, I. Hall, Y. Liou, 1982, Journal of pharmaceutical sciences.

Effects of cis-malonato-diammino platinum (II) on P-388 lymphocytic leukemia cell metabolism.

I. Hall, L. Loeffler, M. H. Holshouser, 1980, Journal of pharmaceutical sciences.

Antitumor agents XLI: Effects of eupaformosanin on nucleic acid, protein, and anaerobic and aerobic glycolytic metabolism of Ehrlich ascites cells.

K. Lee, I. Hall, T. Kimura, 1980, Journal of pharmaceutical sciences.

Effect of Helenalin and Bis(helenalinyl)malonate on Nucleic Acid and Protein Synthesis in Human KB Carcinoma Cells

S. Chaney, K. Lee, A. Grippo, 1987, Pharmaceutical Research.

Antitumor agents LV: Effects of genkwadaphnin and yuanhuacine on nucleic acid synthesis of P-388 lymphocytic leukemia cells.

R. Kasai, K. Lee, K. Tagahara, 1982, Journal of pharmaceutical sciences.

Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolism.

S. Chaney, K. Lee, I. Hall, 1982, Journal of pharmaceutical sciences.

Antitumor agents XXX: Evaluation of α-methylene-γ-lactone-containing agents for inhibition of tumor growth, respiration, and nucleic acid synthesis

K. Lee, M. Haruna, I. Hall, 1978 .

Synthesis of Trimethylamine-[14C]carboxyborane and Trimethylamine-[14C]carboxymethoxyborane and L1210 Leukemia Cell Uptake

S. Wyrick, I. Hall, A. Sood, 1996 .

Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.

I. Hall, J. Shih, K. Rajendran, 1994, Environmental health perspectives.

Anti-inflammatory activity of sesquiterpene lactones and related compounds.

T. G. Waddell, K. Lee, I. Hall, 1979, Journal of pharmaceutical sciences.

CYCLOALKANONES PART 4, ANTIFERTILITY ACTIVITY

C. Piantadosi, I. Hall, G. Carlson, 1975 .

Antitumor agents 68: effects of a series of helenalin derivatives on P-388 lymphocytic leukemia nucleic acid and protein synthesis.

S. Chaney, K. Lee, I. Hall, 1985, Journal of Pharmacy and Science.

Anti‐Osteoporotic activity of metal complexes of amine carboxyboranes

K. Morse, I. Hall, K. Rajendran, 1995 .

Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents

I. Hall, J. Kabara, Timothy G. Matthews, 1985, Lipids.

The Hypolipidemic Activity of a Series of 2,3-Dihydrophthalazine-l,4-dione Derivatives in Rodents

S. Wyrick, I. Hall, J. Chapman, 1986, Pharmaceutical Research.

The Hypolipidemic Activity of Furoic Acid and Furylacrylic Acid Derivatives in Rodents

I. Hall, K. A. Rhyne, M. Knowles, 1985, Pharmaceutical Research.

The Hypolipidemic Activity of N-(p-Chlorobenzoyl)-sulfamate in Rodents and its Effect on Lipid Metabolism

S. Wyrick, I. Hall, A. Dubey, 2004, Pharmaceutical Research.

Biological activity of the hypolipidemic agent, N2-n-butylindazolone.

S. Wyrick, I. Hall, W. Williams, 1984, Journal of pharmaceutical sciences.

Hypolipidemic activity of 3-N-(1',8'-Naphthalimido)propionic acid in rodents.

I. Hall, J. Chapman, G. Cocolas, 1984, Journal of pharmaceutical sciences.

Hypolipidemic activity of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidinone in rodents.

I. Hall, G. Cocolas, P. J. Voorstad, 1984, Journal of pharmaceutical sciences.

Antihyperlipidemic activity of o-chlorobenzylsulfonamide in rodents.

S. Wyrick, I. Hall, A. Dubey, 1984, Journal of pharmaceutical sciences.

Antihyperlipidemic activity of saccharin analogues in rodents.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of pharmaceutical sciences.

Effects of imide analogs on enzymes required for cholesterol and fatty acid synthesis.

I. Hall, J. Chapman, G. Cocolas, 1981, Journal of pharmaceutical sciences.

Antihyperlipidemic activity of sesquiterpene lactones and related compounds.

T. G. Waddell, K. Lee, I. Hall, 1980, Journal of pharmaceutical sciences.

Acute toxicity of amine‐boranes and related derivatives in mice

I. Hall, J. Chang, E. Docks, 1991, Archiv der Pharmazie.

Synthesis of [2-14C]-2′-deoxycytidine-3N-cyanoborane

S. Wyrick, I. Hall, A. Sood, 1991 .

Synthesis of [14C]‐N‐[(trimethylamineboryl) carbonyl]‐phenylalanine‐methyl ester

S. Wyrick, I. Hall, M. C. Miller, 1992 .

Boron analogues of amino acids VI. Synthesis and characterization of di- and tripeptide analogues as antineoplastic, anti-inflammatory and hypolipidemic agents

C. K. Sood, I. Hall, A. Sood, 1990 .

ANTINEOPLASTIC AGENTS. 2. STRUCTURE-ACTIVITY STUDIES ON N-PROTECTED VINYL, 1,2-DIBROMOETHYL, AND CYANOMETHYL ESTERS OF SEVERAL AMINO ACIDS

I. Hall, Z. Sajadi, L. Loeffler, 1978 .

Antineoplastic agents. 1. N-Protected vinyl, 1,2-dihaloethyl, and cyanomethyl esters of phenylalanine.

I. Hall, Z. Sajadi, L. Loeffler, 1977, Journal of medicinal chemistry.

The cytotoxicity of [(N-alkyl-1,3-dioxo-1H,3H-isoindolin-5-yl)oxy]-alkanoic acids in murine and human tissue cultured cell lines.

S. Wyrick, I. Hall, 1995, Anticancer research.

The cytotoxicity of 3-imino-1-oxoisoindolines in murine and human tissue culture cells.

I. Hall, O. T. Wong, 1994, Anti-cancer drugs.

The cytotoxicity of N‐substituted indazolones in murine and human tumor cells

I. Hall, E. Hall, L. Chen, 1993, Anti-cancer drugs.

Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells.

I. Hall, B. Shaw, E. Hall, 1992, Anticancer research.

Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 mice.

S. Chaney, K. Lee, A. Grippo, 1990, Toxicology.

Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.

K. Lee, H. Kim, I. Hall, 1981, Journal of medicinal chemistry.

Antitumor agents XXXVI: Structural elucidation of sesquiterpene lactones microhelenins-A, B, and C, microlenin acetate, and plenolin from Helenium microcephalum.

M. Itoigawa, K. Lee, I. Hall, 1980, Journal of pharmaceutical sciences.

Antitumor agents XXVIII: Structural elucidation of the novel antitumor sesquiterpene lactone, microlenin, from Helenium microcephalum.

K. Lee, I. Hall, Y. Imakura, 1978, Journal of pharmaceutical sciences.

Role of deoxyribonuclease in cancer chemotherapy.

C. Piantadosi, I. Hall, K. Ishaq, 1974, Journal of pharmaceutical sciences.

Cycloalkanones V: synthesis, distribution, and effects on triglyceride metabolism.

C. Piantadosi, I. Hall, R. G. Lamb, 1975, Journal of pharmaceutical sciences.

Antitumor agents LIV: The effects of daphnoretin on in vitro protein synthesis of Ehrlich ascites carcinoma cells and other tissues.

K. Lee, I. Hall, Y. Liou, 1982, Journal of pharmaceutical sciences.

Antitumor agents. 49 tricin, kaempferol-3-O-beta-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wikstroemia indica.

K. Lee, K. Tagahara, M. Haruna, 1981, Journal of natural products.

Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.

I. Hall, O. T. Wong, S. Y. Chen, 1994, Anticancer research.

The cytotoxic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives.

I. Hall, J. Chapman, O. T. Wong, 1994, Anti-cancer drugs.

The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepines.

I. Hall, O. T. Wong, L. Chi, 1993, Anti-cancer drugs.

Hypolipidemic activity of a series of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimides in rodents.

I. Hall, J. Scovill, O. T. Wong, 1990, Biomedica biochimica acta.

Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cells.

S. Chaney, K. Lee, I. Hall, 1983, Journal of pharmaceutical sciences.

Structure-activity relationships for binding and inactivation of rabbit reticulocyte ribosomes by quassinoid antineoplastic agents.

S. Wyrick, S. Chaney, K. Lee, 1983, European journal of biochemistry.

Mechanism of eukaryotic protein synthesis inhibition by brusatol.

S. Chaney, K. Lee, E. A. Stafford, 1981, Biochimica et biophysica acta.

Antitumor agents. XXXV: Effects of brusatol, bruceoside A, and bruceantin on P-388 lymphocytic leukemia cell respiration.

K. Lee, I. Hall, Y. Imakura, 1979, Journal of pharmaceutical sciences.

Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.

S. Chaney, K. Lee, I. Hall, 1987, Biochimica et biophysica acta.

Inhibition of protein synthesis initiation factors by naturally occurring sulfhydryl reactive reagents.

S. Chaney, K. Lee, I. Hall, 1984, Current topics in cellular regulation.

Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells.

S. Chaney, K. Lee, I. Hall, 1983, Biochimica et biophysica acta.

Antitumor agents XXXVIII: Isolation and structural elucidation of novel germacranolides and triterpenes from Elephantopus mollis.

K. Lee, M. Kozuka, I. Hall, 1980, Journal of pharmaceutical sciences.

Cycloalkanones. 9. Comparison of analogues which inhibit cholesterol and fatty acid synthesis.

I. Hall, G. Carlson, 1976, Journal of medicinal chemistry.

Antitumor agents LVI: the protein synthesis inhibition by genkwadaphnin and yuanhuacine of P-388 lymphocytic leukemia cells.

K. Lee, I. Hall, Y. Liou, 1982, Journal of pharmaceutical sciences.

The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell lines.

I. Hall, M. C. Miller, A. Sood, 1995, Anticancer research.

Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.

I. Hall, K. Bastow, M. C. Miller, 1994, Anticancer research.

Boron Containing Nucleic Acids

B. Laster, I. Hall, B. Shaw, 1992 .

Boron analogues of phosphonoacetates: Synthesis, characterization and antitumor properties of sodium diethylphosphite-carboxyborane and related compounds

C. K. Sood, I. Hall, A. Sood, 1991 .

The effects of boron hypolipidemic agents on LDL and HDL receptor binding and related enzyme activities of rat hepatocytes, aorta cells and human fibroblasts.

I. Hall, E. Docks, B. Spielvogel, 1989, Research communications in chemical pathology and pharmacology.

The synthesis and anti-neoplastic activity of N2-isobutyryl-2'-deoxyguanosine-N7-cyanoborane derivatives.

I. Hall, B. Shaw, E. Hall, 1992, Die Pharmazie.

The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells

M. Debnath, I. Hall, E. Hall, 1992, Anti-cancer drugs.

The synthesis and antineoplastic activity of 2'-deoxy-nucleoside-cyanoboranes in murine and human culture cells.

I. Hall, B. Shaw, E. Hall, 1992, Anticancer research.

The cytotoxicity of amine-cyanoboranes, amine-cyanoalkylboranes and aminomethyl-phosphonate cyanoborane adducts against the growth of murine and human tissue culture cells.

K. Morse, I. Hall, A. Sood, 1991, Die Pharmazie.

Hypolipidemic activity of some hydropolyborate salts in rodents.

I. Hall, E. Docks, A. Sood, 1991, Biomedica biochimica acta.

The anti-inflammatory activity of 5H-dibenz[c,e]azepine-5,7(6H)dione, 6,7-dihydro-5H-dibenz[c,e]azepine, N-benzoylbenzamide and 1H-benz[d,e]isoquinoline-1,3(2H)dione derivatives in rodents.

I. Hall, J. Chapman, C. B. Oswald, 1990, Acta pharmaceutica Nordica.

The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism

I. Hall, R. Shrewsbury, A. Sood, 1996, Metal-based drugs.

The Anti-Inflammatory Activity of Boron Derivatives in Rodents

K. Morse, I. Hall, Shang Y. Chen, 1995, Metal-based drugs.

Substituted carboranes and polyhedral hydroborate salts as anti-neoplastics.

I. Hall, S. Karthikeyan, A. Sood, 1998, Anticancer research.

Synthesis and evaluation of the antitumor properties of esters of 2-furoic acid and 2-furylacrylic acid.

I. Hall, Z. Sajadi, J. Chapman, 1984, Journal of pharmaceutical sciences.

Antitumor agents XXIII: Helenalin, and antitumor principle from Anaphalis morrisonicola HAY.

K. Lee, M. Haruna, I. Hall, 1977, Journal of pharmaceutical sciences.

Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonate.

S. Chaney, K. Lee, I. Hall, 1984, Biochemistry.

SESQUITERPENE ANTITUMOR AGENTS- INHIBITORS OF CELLULAR METABOLISM

T. G. Waddell, K. Lee, I. Hall, 1977 .

Teratogenic and other effects produced in mice by norethynodrel and its 3-hydroxymetabolites.

I. Hall, M. Wall, H. Christensen, 1970, Teratology.

Antitumor agents 50. 1 Morindaparvin-A, a new antileukemic anthraquinone, and alizarin-1-methyl ether from Morinda parvifolia, and the antileukemic activity of the related derivatives.

K. Lee, I. Hall, T. Shingu, 1982, Journal of natural products.

Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.

B. Barnes, I. Hall, Y. K. Yan, 2000, Die Pharmazie.

Antitumor agents LXII: synthesis and biological evaluation of podophyllotoxin esters and related derivatives.

K. Lee, I. Hall, R. Levy, 1983, Journal of pharmaceutical sciences.

Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines.

I. Hall, O. Benali-Baitich, G. Bouet, 2000, Die Pharmazie.

Antitumor activity of mono- and dimetallic transition metal carborane complexes of Ta, Fe, Co, Mo, or W.

J. Russell, I. Hall, R. Grimes, 2000, Anticancer research.

Disposition and Distribution of the Cytidine Cyanoborane Adduct, [2-14C]-2′-Deoxycytidine-3N-Cyanoborane, in CF1 Mice

I. Hall, E. Hall, R. Shrewsbury, 1993 .

Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system.

S. Chaney, K. Lee, I. Hall, 1984, Biochemical pharmacology.

Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism.

S. Chaney, K. Lee, I. Hall, 1982, Journal of pharmaceutical sciences.

Antitumor agents XLV: Bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents.

K. Lee, I. Hall, D. Brent, 1982, Journal of pharmaceutical sciences.

Acute Toxic and Teratogenic Effects of Cyclic Imides in Rodents

I. Hall, O. T. Wong, J.-J. Chang, 1994, Archiv der Pharmazie.

Hypolipidemic activity of N-substituted diphenimides in rodents

S. Wyrick, I. Hall, A. R. Murthy, 1985 .

Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.

I. Hall, J. Chapman, G. Cocolas, 1983, Journal of medicinal chemistry.

Effects of two metabolites of norethynodrel on reproductive performance of female rats.

I. Hall, M. Wall, B. Baggett, 1970, Fertility and sterility.

Effects of Hyperbaric Oxygenation on Metabolism III. Succinic Dehydrogenase, Acid Phosphatase, Cathepsin and Soluble Nitrogen.∗

A. P. Sanders, I. Hall, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of Hyperbaric Oxygenation Metabolism II. Oxidative Phosphorylation in Rat Brain, Liver and Kidney.∗

A. P. Sanders, I. Hall, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes.

J. Butts, I. Hall, U. Schwab, 2002, International journal of antimicrobial agents.

Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin

J. Butts, I. Hall, U. Schwab, 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions.

I. Hall, U. Schwab, T. Ives, 2003, International journal of antimicrobial agents.

Synthesis and Cytotoxic Action of 1‐Oxoalkyl and 1,2‐Dioxoalkyl‐1,2,4‐triazolidine‐3,5‐diones in Murine and Human Tissue Cultured Cells

I. Hall, R. Izydore, Christopher Maclauchlin, 1999, Archiv der Pharmazie.

Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions.

J. Butts, I. Hall, U. Schwab, 2001, Research communications in molecular pathology and pharmacology.

Synthesis and antitumor activity of a series of sulfone analogues of 1,4-naphthoquinone.

I. Hall, L. Loeffler, M. H. Holshouser, 1981, Journal of Medicinal Chemistry.

Structure-activity studies on antihyperlipidemic N-benzoylsulfamates, N-benzylsulfamates, and benzylsulfonamides.

S. Wyrick, I. Hall, A. Dubey, 1984, Journal of Pharmacy and Science.

Synthesis and antitumor activity of a series of sulfone analogues of 1,4-naphthoquinone.

I. Hall, L. Loeffler, M. H. Holshouser, 1981, Journal of medicinal chemistry.

Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides

S. Wyrick, J. Maguire, I. Hall, 1984, Pharmaceutical Research.

Comparison of the hypolipidemic activity of cyclic vs. acyclic imides.

S. Wyrick, I. Hall, J. Chapman, 1985, Journal of medicinal chemistry.

In vitro anti-inflammatory effects and immunomodulation by gemifloxacin in stimulated human THP-1 monocytes.

I. Hall, U. Schwab, T. Ives, 2004, Die Pharmazie.

Effect of Plasma TNF‐α on Filgrastim‐Stimulated Hematopoiesis in Mice and Humans

W. Petros, J. Gibbs, I. Hall, 1998 .

Hypolipidemic activity of aliphatic dicarboxylic acids in rodents.

I. Hall, R. Izydore, 1991, Acta pharmaceutica Nordica.

Hypolipidemic activity of indan-1,3-dione derivatives in rodents.

S. Wyrick, I. Hall, A. R. Murthy, 1985, Journal of medicinal chemistry.

The effects of cyclic imides on lipoprotein receptor binding and degradation of rat and human cells and effects on regulatory enzymes of lipid metabolism.

I. Hall, B. Oswald, W. Williams, 1992, Research communications in chemical pathology and pharmacology.

Lasiodiplodin, a potent antileukemic macrolide from Euphorbia splendens

N. Hayashi, I. Hall, R. Wu, 1982 .

Aerosol delivery of muramyl dipeptide to rodent lungs

D. Costa, A. Hickey, I. Hall, 2000, AAPS PharmSci.

Effect of muramyl dipeptide aerosols on guinea pig alveolar macrophages

A. Hickey, I. Hall, R. Pettis, 1995 .

Anti‐inflammatory Activity of Amine‐carboxyboranes in Rodents

I. Hall, K. Rajendran, A. Sood, 1995, Archiv der Pharmazie.

Antitumor agents. 39. Bruceantinoside-A and -B, novel antileukemic quassinoid glucosides from Brucea antidysenterica.

K. Lee, I. Hall, M. Okano, 1981, Journal of Natural Products.

Antitumor agents. 33. Isolation and structural elucidation of bruceoside -A and -B, novel antileukemic quassinoid glycosides, and brucein -D and -E from Brucea javanica

K. Lee, I. Hall, Y. Imakura, 1979 .

Structure activity relationships of imidoN-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents

I. Hall, J. Chapman, O. T. Wong, 1990, Lipids.

The Hypolipidemic Activity of l-N-3-Methylphthalimido-butan-3-semicarbazone in Rodents

I. Hall, J. Chapman, O. T. Wong, 1989, Pharmaceutical Research.

Synthesis and Hypolipidemic Activity of Amine‐Carboxyboranes, and Their Amides and Esters in Rodents

C. K. Sood, K. Morse, I. Hall, 1991, Archiv der Pharmazie.

Hypolipidemic activity of 4-pyrimidinecarboxylic acids in CF1 mice.

I. Hall, W. Williams, G. Cocolas, 1984, Journal of pharmaceutical sciences.

The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF1 Male Mice

I. Hall, Merrill C. Miller, A. Sood, 1999, Metal-Based Drugs.

Pharmaceutical Packaging Technology

D. A. Dean, I. Hall, E. R. Evans, 2000 .

The Cytotoxicity of Symmetrical and Unsymmetrical Bis(thiosemicarbazones) and Their Metal Complexes in Murine and Human Tumor Cells

I. Hall, H. Beraldo, L. Ackerman, 2000, Archiv der Pharmazie.

Anti-inflammatory activity of diazomethyl ketone and chloromethyl ketone analogs prepared from N-tosyl amino acids.

J. Hall, I. Hall, Z. Sajadi, 1980, Journal of pharmaceutical sciences.

Comparison between 6,7-dihydro-5H-dibenz(c,e)azepine and lovastatin as hypolipidemic agents in rats.

D. Reynolds, I. Hall, R. Simlot, 1993, Journal of pharmaceutical sciences.

Hypolipidemic Activity and Toxicity of 3‐Methoxy‐N,N′‐diaminophthalamide in Rodents

I. Hall, A. R. Murthy, B. S. Burnham, 1993, Archiv der Pharmazie.